Home › Markets › Health Care › TPST

Tempest Therapeutics Inc. (TPST)

TPST trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$0.6813
-8.27% on the day
Market cap
$11.3M
Nano cap
Revenue
No annual revenue filed since the period ending 2017-12-31
Net income
No annual revenue filed since the period ending 2017-12-31

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerTPST on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001544227
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

No annual revenue filed since the period ending 2017-12-31.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS
424B32026-10-02
Latest annual report10-K2026-03-30
Latest quarterly / interim10-Q2026-08-13
Latest current report
CURRENT REPORT
8-K2026-09-28
Latest proxyDEFA14A2026-09-16

Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
ACTUActuate Therapeutics Inc.$0.4663-27.56%$11.2M
ENSCEnsysce Biosciences Inc.$0.5725+2.99%$11.1M
AEONAEON Biopharma Inc.$0.2297-6.47%$11.5M
ASBPAspire-Lakewood Holdings Inc.$8.18+5.14%$11.5M
KPRXKiora Pharmaceuticals Inc.$2.47-3.52%$10.9M
LSTALisata Therapeutics Inc.$1.08+2.86%$11.7M
PHIOPhio Pharmaceuticals Corp.$0.9345+1.36%$10.9M
BLRXBioLineRx Ltd.$2.170.00%$10.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier